463
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

The relationship between antenatal indomethacin as a tocolytic drug and neonatal outcomes: a retrospective cohort study

, , , , , , & show all
Pages 2945-2951 | Received 12 Dec 2018, Accepted 27 Sep 2019, Published online: 09 Oct 2019

References

  • World Health Organization. Fact sheet preterm birth; [cited 2018 Feb 19]. Available at http://www.who.int/mediacentre/factsheets/fs363/en/.
  • Practice Bulletin No. 171. Summary: management of preterm labor. Obstet Gynecol. 2016;128(4):931–933.
  • Vogel JP, Nardin JM, Dowswell T, et al. Combination of tocolytic agents for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;7(7):CD006169.
  • Klauser CK, Briery CM, Keiser SD, et al. Effect of antenatal tocolysis on neonatal outcomes. J Matern Fetal Neonatal Med. 2012;25(12):2778–2781.
  • Haas DM, Caldwell DM, Kirkpatrick P, et al. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ. 2012;345(2):e6226–e6226.
  • Briggs GG. Freeman RK. Drugs in pregnancy and lactation. 10th ed. Philadelphia, PA: Wolters Kluwer; 2015.
  • Nederlandse Vereniging voor Obstetrie en Gynaecologie. Richtlijn dreigende vroeggeboorte 2.0. 2011.
  • Hammers AL, Sanchez-Ramos L, Kaunitz AM. Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis. Am J Obstet Gynecol. 2015;212(4):505.e1–505.13.
  • Amin SB, Sinkin RA, Glantz JC. Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes. Am J Obstet Gynecol. 2007;197(5):486.e1–486.10.
  • Loe SM, Sanchez-Ramos L, Kaunitz AM. Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol. 2005;106(1):173–179.
  • Gordon PV, Swanson JR, Clark R. Antenatal indomethacin is more likely associated with spontaneous intestinal perforation rather than NEC. Am J Obstet Gynecol. 2008;198(6):725. Author reply 726.
  • Norton ME, Merrill J, Cooper BA, et al. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med. 1993;329(22):1602–1607.
  • Gordon PV. Understanding intestinal vulnerability to perforation in the extremely low birth weight infant. Pediatr Res. 2009;65(2):138–144.
  • Duff P. Preterm prelabor rupture of membranes. [cited 2018 May 2; updated 2018]. Available at http://www.uptodate.com.
  • Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1–7.
  • Papile LA, Burstein J, Burstein R, et al. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92(4):529–534.
  • de Vries LS, Eken P, Dubowitz LM. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res. 1992;49(1):1–6.
  • Alpan G, Eyal F, Vinograd I, et al. Localized intestinal perforations after enteral administration of indomethacin in premature infants. J Pediatr. 1985;106(2):277–281.
  • Kawase Y, Ishii T, Arai H, et al. Gastrointestinal perforation in very low-birthweight infants. Pediatr Int. 2006;48(6):599–603.
  • Meyer CL, Payne NR, Roback SA. Spontaneous, isolated intestinal perforations in neonates with birth weight less than 1,000 g not associated with necrotizing enterocolitis. J Pediatr Surg. 1991;26(6):714–717.
  • Pineda-Peña EA, Martínez-Pérez Y, Galicia-Moreno M, et al. Participation of the anti-inflammatory and antioxidative activity of docosahexaenoic acid on indomethacin-induced gastric injury model. Eur J Pharmacol. 2018;818:585–592.
  • Wadhawan R, Oh W, Vohr BR, et al. Spontaneous intestinal perforation in extremely low birth weight infants: association with indometacin therapy and effects on neurodevelopmental outcomes at 18–22 months corrected age. Arch Dis Child Fetal Neonatal Ed. 2013;98(2):F127–F132.
  • Attridge JT, Clark R, Walker MW, et al. New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol. 2006;26(2):93–99.
  • Schmidt B, Davis P, Moddemann D, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001;344(26):1966–1972.
  • Kelleher J, Salas AA, Bhat R, et al. Prophylactic indomethacin and intestinal perforation in extremely low birth weight infants. Pediatrics. 2014;134(5):e1369–e1377.
  • Macones GA, Marder SJ, Clothier B, et al. The controversy surrounding indomethacin for tocolysis. Am J Obstet Gynecol. 2001;184(3):264–272.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.